Junsik Park

19PUBLICATIONS
63CO-AUTHORS
Tissue engineeringNeural engineeringApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jun 03, 2025
Co-blockade of TGFβ and PD-1 Reinvigorates Glioblastoma-Infiltrating CD8+ T Cells That Characteristically Upregulate TGFβRI Expression.

A-Reum Kim, Seung Hyuck Jeon, Junsik Park

|Mar 05, 2025
Neoadjuvant Chemotherapy with Dual Immune Checkpoint Inhibitors for Advanced-Stage Ovarian Cancer: Final Analysis of TRU-D Phase II Nonrandomized Clinical Trial.

Junsik Park, Je-Gun Joung, Myong Cheol Lim

|Jun 28, 2024
OPERA: a phase II trial of oregovomab plus non-platinum chemotherapy in PARP inhibitor/platinum-resistant ovarian cancer.

Junsik Park, Hyun Woong Cho, Myong Cheol Lim

Pageof 4